Press release
Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalence & Innovative Treatments 2025 | DataM Intelligence
Gout Therapeutics Market
The Gout Therapeutics Market size was valued USD 1.9 billion in 2021 and is estimated to reach USD 4.1 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).
Gout Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/gout-therapeutics-market?sz
The Gout Therapeutics Market refers to the global industry focused on developing and providing treatments to manage gout, a type of inflammatory arthritis caused by excess uric acid. It includes pharmaceuticals such as urate-lowering therapies, anti-inflammatory drugs, and biologics aimed at reducing pain, preventing flare-ups, and improving patient outcomes through effective disease management.
Industry News of USA and Japan:
USA:
June 2025: FDA granted accelerated approval to a new oral urate-lowering drug for treatment-resistant gout.
July 2025: Major pharmaceutical collaboration announced between a leading US biotech and a global pharma company to develop next-generation biologics for chronic gout.
Japan:
June 2025: Japan's regulatory authority approved a biosimilar version of a popular uric acid-lowering agent, expanding patient access.
August 2025: A Japanese research institute published positive Phase III results for a novel gout therapy targeting inflammation pathways.
Key Players:
Novartis International AG
GlaxoSmithKline PLC
Lannett Company, Inc
Mylan NV
Boehringer Ingelheim
Horizon Therapeutics plc
Regeneron Pharmaceuticals
Takeda Pharmaceutical Company Ltd
Teijin Pharma Ltd
Romeg Therapeutics, LLC.
Growth Forecast Projected:
The Global Gout Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Gout Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=gout-therapeutics-market
Market Segmentation:
By Drug Class: Non-steroidal Anti-inflammatory Drugs (NSAIDs), Anti-hyperuricemic Agents (Urate-Lowering Drugs), Corticosteroids, Colchicine, Others.
By Application: Acute Gout, Chronic Gout.
By End User: Hospital Pharmacies, Drug Stores, Online Channels, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/gout-therapeutics-market
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Gout Therapeutics market?
➠ Who are the leading manufacturers in the global Gout Therapeutics industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Gout Therapeutics industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Gout Therapeutics market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalence & Innovative Treatments 2025 | DataM Intelligence here
News-ID: 4159328 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Optically Clear Adhesive Market Poised for Rapid Growth Amid Risin …
Market Overview:
The Global Optically Clear Adhesive Market is expected to grow at a CAGR of 8.5% during the forecast period (2024-2031).
The Optically Clear Adhesive Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative…
United States Adhesion Barrier Market Set for Explosive Growth: Innovations Driv …
Market Overview:
The Global Adhesion Barrier Market is expected to grow at a CAGR of 7.1% during the forecasting period (2024-2031).
The Adhesion Barrier Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods,…
United Kingdom Liver Cancer Therapeutics Market is expected to reach US$ 13.16 b …
Market Size and Forecast:
The Liver Cancer Therapeutics Market Size reached US$ 3.36 billion in 2024, and is expected to reach US$ 13.16 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.
The Liver Cancer Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
United States Polycaprolactone (PCL) Market Set to Soar: Innovations in Biodegra …
Market Overview:
The Global Polycaprolactone (PCL) Market is estimated to reach at a Significant CAGR during the forecast period 2024-2031.
The Polycaprolactone (PCL) Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
